NCT02523417View on ClinicalTrials.gov

HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Breast Cancer
Interventions
PROCEDURE

interventional therapy

breast cancer patients received HepaSphere interventional therapy using the digital subtraction angiography（DSA）

Trial Locations (1)

510000

Central laboratory in Fuda cancer hospital, Guangzhou

All Listed Sponsors
lead

Fuda Cancer Hospital, Guangzhou

OTHER

NCT02523417 - HepaSphere Interventional Therapy Using Digital Subtraction Angiography（DSA）for Breast Cancer | Biotech Hunter | Biotech Hunter